A new study suggests kids with peanut allergy may not need high-dose oral immunotherapy to build protection. A small daily dose may help raise their reaction threshold with fewer side effects.
#PeanutAllergy #FoodAllergy #AllergyResearch https://www.growingyourbaby.com/smaller-peanut-doses-show-promise-in-allergy-treatment-study/
Smaller Peanut Doses Show Promise in Allergy Treatment Study
Researchers say children with peanut allergy may not need high-dose oral immunotherapy to gain meaningful protection from accidental exposure.
New allergy therapies use microscopic daily doses of allergens like peanuts to help the body slowly build tolerance. Some people can eventually eat the food again, while others see reduced reactions. A huge step forward for allergy research.
Watch the full discussion: https://youtu.be/7YA9EOMqZcw
#AllergyResearch #PeanutAllergy #Immunotherapy #HealthTech #MedicalInnovation #PublicHealth
A new immune cell may explain why city kids get more allergies than rural kids β and open the door to future prevention. #ChildHealth #AllergyResearch #MicrobiomeMatters
https://geekoo.news/why-city-kids-are-more-prone-to-allergies/
Why City Kids Are More Prone to Allergies | Geekoo
New research identifies a pro-allergic immune cell more common in urban babies β and may hold the key to preventing childhood allergies.
Anaphylaxis Treatment Uncertainty Persists for Patients and Professionals
Two new studies showed the need for improved patient education and clinical protocols.
π₯π The NHS is running a trial called The Natasha Clinical Trial, which is helping children and young adults with food allergies. Instead of costly drugs, they're using everyday foods to build tolerance. This ground-breaking approach could lead to a future without allergies for many. ππ§¬
@goodnews
#AllergyResearch #NHS #TheNatashaClinicalTrial #GoodNews
https://www.narf.org.uk/the-natasha-clinical-trial-update
The Natasha Clinical Trial β The Natasha Allergy Research Foundation
Pioneering NATASHA Trial offers hope that βeveryday foodsβ will be used in the future to treat people living with food allergies.
The three-year oral immunotherapy (OIT) trial will be the first major study funded by The Natasha Allergy Research Foundation, the charity set up by the parents of Nata
growingyourbaby
servenomaster
Geekoo
Marcel SIneM(S)US
Good News Community